Novel head-mounted device shows promise in alleviating depression symptoms

FHS
May 8, 2024
11:23 am

A head-mounted device that generates an ultra-low frequency ultralow magnetic field has been found to improve the symptoms of four male patients diagnosed with major depressive disorder.

MSD expands vaccine production with new $1bn facility

MSD has invested $12bn in US capital since 2018. Credit: Katherine Welles/Shutterstock. MSD has opened a $1bn facility in Durham, in the US state of

March 11, 2025

Mouse models shed light on the effects of metformin use during pregnancy on offspring

With the rise in gestational diabetes and metabolic disorders during pregnancy, metformin is also being prescribed more frequently.

March 18, 2024

Silence unveils more PhI data for siRNA drug in new cardiovascular race targeting Lp(a)

Silence Therapeutics’ siRNA asset showed hints of efficacy in cardiovascular disease patients enrolled in a Phase I trial amid recent readouts from pipeline rivals backed

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.